Electric implant aims to ease Amputees' lingering pain
NCT ID NCT07571239
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an implanted device called Altius can reduce persistent pain in people who have lost a leg and still hurt despite prior nerve surgery. About 32 adults will get the device and report changes in pain, mood, and how often they use their prosthetic limb. The goal is to see if direct nerve stimulation can improve daily life for amputees with stubborn pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Altius Direct Electrical Nerve Stimulation System (implanted device)
What this could lead to
If it works, this could offer a new way to manage stubborn pain after amputation and help people use their prosthetic limb more comfortably.
What could go wrong
This is a small, early study with only 32 people and no comparison group, so results may not apply to everyone. The device requires surgery and may not relieve pain for all users.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMPUTATION; LOWER EXTREMITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
New York, New York, 10016, United States